{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:28:42Z","timestamp":1773296922296,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1433,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1998,2]]},"abstract":"<jats:p> <jats:bold>\n            <jats:italic>Aims<\/jats:italic>\n          <\/jats:bold>\u2007To compare the lung delivery of salbutamol from a commonly used constant output open vent jet nebuliser (Sidestream) with use of both a conventional large volume plastic spacer (Volumatic) and a novel small volume metal spacer (NebuChamber). This was assessed using the early lung absorption profile of salbutamol over the first 20\u2003min after inhalation.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Methods<\/jats:italic>\n          <\/jats:bold>\u2007Twelve healthy volunteers were studied in a randomized single (investigator) blind crossover design. Single 1200\u2003\u03bcg nominal doses salbutamol from a CFC\u2010free metered\u2010dose inhaler (12 sequential 100\u2003\u03bcg puffs of Airomir) were delivered via the Volumatic and NebuChamber spacers. A single 1200\u2003\u03bcg nominal dose of salbutamol was given as a 4ml fill volume from a Sidestream nebuliser with mouthpiece. Mouth rinsing was performed after each drug sequence. Plasma salbutamol was measured at 5, 10, 15 and 20\u2003min after the last dose of each inhalation sequence, with calculation of maximal concentration (<jats:italic>C<\/jats:italic><jats:sub>max<\/jats:sub>\u200a) and average concentration over 20\u2003min (<jats:italic>C<\/jats:italic><jats:sub>av<\/jats:sub>\u200a). Systemic \u03b2<jats:sub>2<\/jats:sub>\u2010responses were measured as plasma potassium, tremor and heart rate.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Results<\/jats:italic>\n          <\/jats:bold>\u2007Both the Volumatic and the NebuChamber spacers produced significantly greater salbutamol concentration than the Sidestream nebuliser. For <jats:italic>C<\/jats:italic><jats:sub>av<\/jats:sub> this amounted to a 7.34\u2010fold difference (95%CI 5.31 to 9.38) between Volumatic <jats:italic>vs<\/jats:italic> Sidestream, and a 7.04\u2010fold difference (95%CI 4.91 to 9.17) for NebuChamber <jats:italic>vs<\/jats:italic> Sidestream. Similar differences were found for the extrapulmonary \u03b2<jats:sub>2<\/jats:sub>\u2010responses. There were no significant differences in either salbutamol concentration or extrapulmonary \u03b2<jats:sub>2<\/jats:sub>\u2010responses between the Volumatic and NebuChamber spacers.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Conclusions<\/jats:italic>\n          <\/jats:bold>\u2007We found that, <jats:italic>in vivo<\/jats:italic>, both the Volumatic and the NebuChamber spacers produced seven\u2010fold greater lung delivery of salbutamol than the Sidestream nebuliser when comparing microgram equivalent nominal doses, in terms of the early lung absorption profile.<\/jats:p>","DOI":"10.1046\/j.1365-2125.1998.00648.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T04:30:47Z","timestamp":1047357047000},"page":"160-163","source":"Crossref","is-referenced-by-count":19,"title":["Lung delivery of non\u2010CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer"],"prefix":"10.1111","volume":"45","author":[{"given":"B. J.","family":"Lipworth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.91.6.804"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.91.6.799"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1183\/09031936.93.02040377","article-title":"Sympathomimetics in acute severe asthma: inhaled or parenteral, nebuliser or spacer?","volume":"2","author":"Noseda A","year":"1989","journal-title":"Eur Respir J"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.88.2.276"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.106.6.1788"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.10.981"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1995.tb04538.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.73.3.226"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.10.985"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF00562546","article-title":". Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma.","volume":"37","author":"Lipworth BJ","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.6.658"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10081820"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.3.325"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1996.tb00191.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558154"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.3.835"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.103.3.665"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2125.1998.00648.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2125.1998.00648.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2125.1998.00648.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2125.1998.00648.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:29:50Z","timestamp":1694431790000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2125.1998.00648.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1046\/j.1365-2125.1998.00648.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2125.1998.00648.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}